Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
16.07. | Xebra Brands Ltd (2): Xebra hopes to file fiscal 2025 financials by Aug. 29 | 2 | Stockwatch | ||
16.07. | Xebra Brands Ltd: Xebra Provides Update on Management Cease Trade Order | 144 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / July 16, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC), an international cannabis company, is providing an update to its previously disclosed... ► Artikel lesen | |
03.07. | Xebra Brands Ltd (2): Xebra Brands cancels LOI to acquire BSK | 5 | Stockwatch | ||
XEBRA BRANDS Aktie jetzt für 0€ handeln | |||||
03.07. | Xebra Brands Ltd. Terminates Letter of Intent to Acquire BSK Holdings Inc.; Announces Delay in Completion of Annual Filings and MCTO; Announces Loan | 360 | ACCESS Newswire | Continued Partnership to Bring ELEMENTS CBD Product Line to U.S. Market VANCOUVER, BC / ACCESS Newswire / July 2, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0)... ► Artikel lesen | |
24.06. | Xebra Brands Ltd (2): Xebra Brands clarifies not-yet-granted MCTO | 7 | Stockwatch | ||
23.06. | Xebra Brands Ltd: Xebra Announces Corporate Update and Correction Notice of Press Release Announcing Grant of Management Cease Trade Order | 341 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / June 23, 2025 / Xebra Brands Ltd. (CSE:XBRA) (the "Company" or "Xebra Brands") announces a correction to the Company's press release dated June 23, 2025 announcing... ► Artikel lesen | |
23.06. | Xebra Brands Ltd (2): Xebra Brands to be late to file fiscal 2025 results | 2 | Stockwatch | ||
23.06. | Xebra Brands Ltd: Xebra Announces Delay in Filing Financial Statements | 232 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / June 23, 2025 / Xebra Brands Ltd. ("Xebra") (XBRA:CSE)(XBRAF:OTCQB)(9YC:FSE), announces today that it was not in a position to file its audited annual financial statements... ► Artikel lesen | |
13.05. | Xebra Brands Ltd (2): Xebra to launch Elements CBD line in U.S. this summer | 4 | Stockwatch | ||
13.05. | Xebra Brands Ltd: Xebra Brands Advances Commercialization Efforts with NF Skin | 255 | ACCESS Newswire | Summer 2025 Launch of ELEMENTS CBD Product Line in United States VANCOUVER, BC / ACCESS Newswire / May 13, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a leading... ► Artikel lesen | |
25.04. | Xebra Brands Ltd (2): Xebra Brands enters LOI to acquire BSK Holdings | 4 | Stockwatch | ||
24.04. | XFRA 9YC0: WIEDERAUFNAHME/RESUMPTION | 317 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
24.04. | Xebra Brands Ltd (2): Xebra Brands to resume at 8 a.m. PT | 3 | Stockwatch | ||
24.04. | Xebra Brands Ltd: Xebra Brands Announces Letter of Intent to Acquire CBD E-Commerce Company BSK Holdings Inc. | 422 | ACCESS Newswire | NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER, BC / ACCESS... ► Artikel lesen | |
23.04. | XFRA 9YC0: AUSSETZUNG/SUSPENSION | 646 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILXEBRA BRANDS CL.A... ► Artikel lesen | |
23.04. | Xebra Brands Ltd (2): Xebra Brands halted at 7:48 a.m. PT | 6 | Stockwatch | ||
15.04. | Xebra Brands Ltd (2): Xebra Brands strikes partnership for U.S. CBD launch | 3 | Stockwatch | ||
15.04. | Xebra Brands Ltd: Xebra Brands Executes Manufacturing and Distribution Agreement to Launch CBD Product Line in the U.S. | 334 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / April 15, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a leading innovator in the North American cannabis sector, is pleased... ► Artikel lesen | |
10.04. | Xebra Brands Ltd (2): Xebra calls out for partners of all stripe in Mexico | 3 | Stockwatch | ||
10.04. | Xebra Brands Ltd: Xebra Brands Launches National RFP to Establish Cannabis Cultivation Partnerships Across Mexico | 348 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / April 10, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a trailblazer in the Mexican cannabis sector and the sole company legally... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BAYER | 27,350 | -3,03 % | Bayer: Aktie mit Kaufsignal - jetzt zuschlagen? | Am Mittwoch, den 06. August, wird das DAX-Unternehmen Bayer die Zahlen für das zweite Quartal vorlegen. Im Vorfeld übernehmen die Bullen peu à peu das Ruder. So steigt das Papier am Donnerstag sogar... ► Artikel lesen | |
AURORA CANNABIS | 3,880 | -1,52 % | Droht der nächste Schock?: Canopy Growth, Tilray & Co. zittern. Aurora Cannabis veröffentlicht Zahlen | © Foto: adobe.stock.comDie Quartalsberichtssaison macht keinen Bogen um den Cannabis-Sektor. Die Quartalsberichte von Canopy, Tilray & Co. sind die sprichwörtliche Wundertüte. Selten beinhalten diese... ► Artikel lesen | |
CANOPY GROWTH | 0,914 | -0,98 % | Canopy Growth names Miles Worne as European markets managing director | ||
TILRAY BRANDS | 0,501 | -6,74 % | Tilray's Unique Strategy Could Make It A Winner As Cannabis, Beverages, And Wellness Mature | ||
INNOCAN PHARMA | 0,143 | -1,38 % | Innocan Pharma gibt die öffentliche Einreichung der Registrierungserklärung für den geplanten Börsengang in den USA bekannt | Herzliya, Israel und Calgary, Alberta - 23. Juli 2025 / IRW-Press / Innocan Pharma Corporation ("Innocan" oder das "Unternehmen") (CSE: INNO) (FWB: IP4) (OTCQB: INNPF) freut sich bekannt zu geben... ► Artikel lesen | |
CRONOS GROUP | 1,722 | -1,43 % | Cronos Group Inc: Cronos Group to hold Q2 2025 results call Aug. 7 | ||
SYNBIOTIC | 2,950 | -1,01 % | SynBiotic: Sportliche Ziele | Der Druck lässt nach. Die Chartmarke um 3 Euro scheint zu halten. Nach schwierigen Jahren hoffen die Aktionäre von SynBiotic momentan wieder auf bessere Zeiten. Unverkennbar: Daniel Kruse, der CEO des... ► Artikel lesen | |
NEKTAR THERAPEUTICS | 18,900 | -2,58 % | Nektar gets FDA fast track status for alopecia areata drug | ||
ORAMED PHARMACEUTICALS | 1,930 | +2,52 % | Oramed Pharmaceuticals Inc.: Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical | Oramed leverages its strategic capital markets expertise to support Alpha Tau's breakthrough cancer therapy technology
Accelerating multiple late-stage cancer therapies... ► Artikel lesen | |
OPKO HEALTH | 1,141 | -3,11 % | OPKO Health, Inc.: OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting | MIAMI and JERUSALEM, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX) ("Entera") today announced that new pharmacologic and pharmacokinetic in vivo... ► Artikel lesen | |
JAGUAR HEALTH | 2,010 | -6,07 % | Jaguar Health, Inc.: Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs | Company strategy: In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally approved for CID, to regulatory approval and commercialization... ► Artikel lesen | |
SELLAS LIFE SCIENCES | 1,412 | -2,49 % | SELLAS Life Sciences Group, Inc.: SELLAS Meets All Primary Endpoints in Phase 2 Trial of SLS009 in r/r AML and Receives FDA Guidance to Advance into First-Line Therapy Study | The Trial Exceeded Target Overall Response Rate (ORR) of 20%, with 44% Response Rate Among Patients with Acute Myeloid Leukemia-Myelodysplasia-Related Changes (AML MR) Treated at Optimal Dose of 30... ► Artikel lesen | |
XORTX THERAPEUTICS | 0,660 | -0,30 % | XORTX gibt 3-Millionen-USD-Platzierung bekannt | - Erlös wird für die Weiterentwicklung der XORTX-Programme zur Gichtbehandlung verwendet -
CALGARY, AB, 19. Mai 2025 / IRW-Press / XORTX Therapeutics Inc. ("XORTX" oder das "Unternehmen")... ► Artikel lesen | |
NUMINUS WELLNESS | 0,027 | -100,00 % | Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2024 Results | Q4 Fiscal 2024 Highlights1Revenue of $1.2 million, a 16.4% increase over Q3 2024Gross profit of $0.3 million, compared to a loss of $0.05 million in Q3 2024Cash position of $2.0 million as of August... ► Artikel lesen | |
CANNOVUM CANNABIS | 0,233 | -8,27 % | EQS-News: Cannovum Cannabis AG: Abwicklung bzw. Veräußerung der Beteiligungen im Cannabis-Bereich | EQS-News: Cannovum Cannabis AG
/ Schlagwort(e): Strategische Unternehmensentscheidung/Sonstiges
Cannovum Cannabis AG: Abwicklung bzw. Veräußerung der Beteiligungen im Cannabis-Bereich... ► Artikel lesen |